Cellcept 500 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FNR3G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,910
Award facts
- Contract value 100% obligated
- $21,909.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,909.55 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office.
CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly used in military and veteran healthcare systems for organ transplant recipients and patients with autoimmune conditions. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement, supplying specialized medications across multiple therapeutic domains to support Department of Defense healthcare programs globally. The DLA Medical Supply Chain relies on such competitive delivery orders to ensure timely availability of essential pharmaceutical products to military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FNR3G?
SPE2DR26FNR3G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FNR3G worth?
The government has obligated $21,910 on SPE2DR26FNR3G.
Is contract SPE2DR26FNR3G an order under another contract?
Yes. SPE2DR26FNR3G is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNR3G competed?
The extent of competition for SPE2DR26FNR3G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award